These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 2455597

  • 1. Comparison between tissue antigen analysis and plasma determinations for TPA and CEA in transitional cell carcinomas and in tumorfree urothelium of the urinary bladder.
    Vogel J, Oehr P, Maisey R, Adolphs HD.
    Cancer Detect Prev; 1988; 11(3-6):389-96. PubMed ID: 2455597
    [Abstract] [Full Text] [Related]

  • 2. Immunohistological investigations of carcinoembryonic antigen (CEA) in urothelial carcinomas.
    Feil G, Wechsel HW, Nelde HJ, Bichler KH.
    Anticancer Res; 1999; 19(4A):2591-7. PubMed ID: 10470200
    [Abstract] [Full Text] [Related]

  • 3. [Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer].
    Takashi M, Murase T, Mitsuya H, Koshikawa T, Nagura H, Haimoto H.
    Hinyokika Kiyo; 1986 Apr; 32(4):541-52. PubMed ID: 2426931
    [Abstract] [Full Text] [Related]

  • 4. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
    Björklund V, Björklund B.
    Cancer Detect Prev; 1983 Apr; 6(1-2):193-8. PubMed ID: 6883380
    [Abstract] [Full Text] [Related]

  • 5. [Evaluation of serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Tozuka K, Yonese Y, Nakagami Y, Minowa T, Hiraoka Y, Yamada N, Hikima N, Ishii Y, Tannowa K, Fujioka Y.
    Gan To Kagaku Ryoho; 1984 May; 11(5):1078-83. PubMed ID: 6721513
    [Abstract] [Full Text] [Related]

  • 6. [A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage].
    Meregalli M, Antoniazzi V, Torchio G, Colombo E, Bocchi M, Sonzini E, Lino S.
    Minerva Med; 1989 Apr; 80(4):345-7. PubMed ID: 2725935
    [Abstract] [Full Text] [Related]

  • 7. Tissue polypeptide antigen and carcinoembryonic antigen in colon tumors: serum levels and immunohistochemical localization.
    Bombardieri E, Jotti GS, Cocciolo MG, Mori M, Rusconi A, Rusca M, Seregni E, Becchi G, Fontanesi M, Tardini A.
    Cancer Detect Prev; 1985 Apr; 8(1-2):219-26. PubMed ID: 4064041
    [Abstract] [Full Text] [Related]

  • 8. Plasma carcinoembryonic antigen and tissue polypeptide antigen levels in lung cancer: correlation with cell types and stage.
    Salvati F, Antilli A, Cruciani AR, Pau F, Flore F, Munno R, De Angelis G, Cipri A, Pigorini F.
    Cancer Detect Prev; 1985 Apr; 8(1-2):111-4. PubMed ID: 4064030
    [Abstract] [Full Text] [Related]

  • 9. [Immunohistochemical determination of antigen 19-9 (CA 19-9) in transitional carcinoma of the bladder].
    Casetta G, Cavallini A, Piana P, Squintone L, Vottero M, Tizzani A.
    Minerva Urol Nefrol; 1992 Apr; 44(3):169-72. PubMed ID: 1492266
    [Abstract] [Full Text] [Related]

  • 10. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF, Epstein JI.
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [Abstract] [Full Text] [Related]

  • 11. Tissue polypeptide antigen in normal and neoplastic urinary bladder. Preliminary reports.
    Senatore S, Attolini A, Luccarelli S, Candita F, Trabucco M.
    Oncology; 1987 Mar; 44(2):118-23. PubMed ID: 2437508
    [Abstract] [Full Text] [Related]

  • 12. [Usefulness of carcinoembryonic antigen in transitional cell carcinoma of the bladder].
    Moreno Sierra J, Ortega MD, Blanco Jimenez E, Maestro de las Casas ML, Delgado Marti JA, Hermida Gutierrez J, Salinas Casado J, Esteban Fuertes M, Resel Estévez L.
    Arch Esp Urol; 1994 Mar; 47(1):39-42. PubMed ID: 8192496
    [Abstract] [Full Text] [Related]

  • 13. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
    Asamoto M, Fukushima S, Tatemoto Y, Yamada K, Yuba R, Mori M.
    Anticancer Res; 1989 Mar; 9(2):319-26. PubMed ID: 2751258
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI.
    Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
    [Abstract] [Full Text] [Related]

  • 16. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors].
    Fujioka T, Tanji S, Koike H, Kubo T, Ohhori T.
    Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765
    [Abstract] [Full Text] [Related]

  • 17. Combined use of carcinoembryonic antigen and tissue polypeptide antigen in oncologic therapy and surveillance.
    Lüthgens M, Schlegel G.
    Cancer Detect Prev; 1983 Oct; 6(1-2):51-9. PubMed ID: 6883393
    [Abstract] [Full Text] [Related]

  • 18. Carcinoembryonic antigen in cytological specimens of urothelial carcinoma.
    Holmberg V, Wahren B, Esposti PL.
    Cytometry; 1984 Jul; 5(4):437-41. PubMed ID: 6380996
    [Abstract] [Full Text] [Related]

  • 19. [Tissue polypeptide antigen and carcinoembryonic antigen in bladder neoplasms].
    Krajewska B, Stelmach W, Lutz W, Matych J.
    Med Pr; 1995 Jul; 46(1):7-16. PubMed ID: 9732842
    [Abstract] [Full Text] [Related]

  • 20. [Diagnostic predictability of CEA and TPA tumor markers in bronchoalveolar lavage fluid].
    Loos U, Oehr P, Genske F, Schlack W.
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():235-7. PubMed ID: 3174571
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.